Filter by Industry
Filter by Topic
Webinar recap: Clear data, clear strategy—Practical steps to drive growth and results
Try these data-driven consumer marketing tips to optimize your full-funnel healthcare marketing strategy today.
How drug and device pricing shape insurance underwriting
See how drug and device pricing list, net, rebates, and value-based deals shapes payer underwriting, formularies, and coverage decisions.
Top trends of 2026: Healthcare policy shifts will reshape the business of care in 2026
Explore 2025 healthcare policy shifts from ACA updates and Medicaid cuts to AI and PBM reform. Learn how they’ll reshape the business of care in 2026.
Top trends of 2026: Emerging therapies and diagnostics are on track to transform cancer care
From mRNA vaccines to radiopharmaceuticals, a new generation of technologies is set to redefine how cancer is detected, treated, and managed—creating…
Top healthcare trends of 2026: Rising expenses drive demand for cost-containment strategies
High healthcare costs driven by GLP-1 drugs and mental health spending by push payors, employers, and providers to adopt targeted cost-containment…
5 hospital bad debt statistics you need to know
Explore key hospital bad debt stats: rising unpaid patient balances, self-pay trends, and daily increases. Learn how bad debt affects hospital…
Top trends of 2026: Cybersecurity breaches emphasize the importance of secure tech in healthcare
Cybersecurity breaches are increasing in number and magnitude causing healthcare IT departments and provider organizations to examine impacts on…
Webinar recap: Proven strategies to drive net-new patient growth
Discover how leading healthcare organizations use data-driven strategies to drive patient growth, retention, and ROI.
A ton of organizations are using (our) reference and affiliation data to sell into healthcare—here's why
Discover why organizations use our healthcare affiliation and reference data to improve healthcare sales, boost targeting, and increase ROI.
Top trends of 2026: New PBM rules will put market access strategies to the test
State regulators ramp up PBM oversight in 2026 cracking down on opaque pricing, rebate structures, and anti-competitive tactics to improve drug…